Lyrica Pregabalin Capsule 150 mg (Pregabalin)
Pregabalin 150mg
Hard capsule · Prescription medication
Light Pharmtech Co., Ltd.
MFDS item code 201902276 · Approved 2019.04.15
This product's status changed to Expired on 2024.04.15. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of neuropathic pain, adjunctive treatment of partial seizures, and treatment of fibromyalgia
This medication is used to treat peripheral and central neuropathic pain in adults. It is also used as an adjunctive treatment for partial seizures in patients with epilepsy, applicable both with or without secondary generalized symptoms. Additionally, it is effective in alleviating the symptoms of fibromyalgia. Thus, this drug assists in the management of various neurological conditions and pain.
This medicine is administered orally, with or without food, in 2 divided doses of the total daily dose of pregabalin. As this medicine is primarily excreted by the kidneys, the dose should be adjusted in patients with impaired renal function. (See section ‘5. Patients with Renal Impairment’) 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: This medicine may be administered at an initial dose of 150 mg/day. Based on the response and tolerability of each patient, the dose may be increased to 300 mg/day after 3 to 7 days. If necessary, it may thereafter be increased at 7-day intervals to a maximum of 600 mg/day. 2) Central neuropathic pain Adults: This medicine may be administered at an initial dose of 150 mg/day. Based on the response and tolerability of each patient, the dose may be increased to 300 mg/day after 1 week. After an additional 1 week, the dose may be increased to the target daily dose of 600 mg. If the target daily dose is not tolerated, a dose reduction may be considered. (See section ‘4. Discontinuation’) 2. Epilepsy Adults: This medicine may be administered at an initial dose of 150 mg/day. Based on the response and tolerability of each patient, the dose may be increased to 300 mg/day after 1 week. If necessary, it may thereafter be increased at 7-day intervals to a maximum of 600 mg/day. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300 mg to 450 mg/day. The initial dose is 75 mg twice daily (150 mg/day), and based on efficacy and tolerability, it may be increased within 1 week to 150 mg twice daily (300 mg/day). For patients who do not experience sufficient benefit at a dose of 300 mg/day, the dose may be increased within 1 week to 225 mg twice daily (450 mg/day). Clinical studies were also conducted at a dose of 600 mg/day; however, there is no evidence of additional benefit or adequate tolerability at this dose. Considering dose-dependent adverse reactions, doses exceeding 450 mg/day are not recommended. 4. Discontinuation Based on current clinical experience, if treatment with this medicine is discontinued, it should be tapered gradually over at least 1 week. 5. Patients with Renal Impairment After entering the systemic circulation, this medicine is primarily excreted by the kidneys as unchanged drug. As the clearance of this medicine is directly affected by creatinine clearance, dose reductions in patients with impaired renal function should be individualized based on creatinine clearance. Creatinine clearance [Table 1] is determined using the following formula. *: For women, multiply the result obtained from the above calculation by 0.85. This medicine is effectively removed from plasma by hemodialysis (approximately 50% within 4 hours). In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, a supplemental dose should be administered immediately after each 4-hour hemodialysis session. [Table 1]. Pregabalin dosage based on renal function Creatinine clearance (CLcr), (mL/min) ≥60: starting dose 150 (mg/day), maximum dose 600 (mg/day), BID or TID ≥30 -<60: starting dose 75 (mg/day), maximum dose 300 (mg/day), BID or TID ≥15 -<30: starting dose 25-50 (mg/day), maximum dose 150 (mg/day), QD or BID <15: starting dose 25 (mg/day), maximum dose 75 (mg/day), QD Supplemental dose after hemodialysis: starting dose 25, maximum dose 100, single dose b TID = total daily dose administered in 3 divided doses BID = total daily dose administered in 2 divided doses QD = administered once daily a: The total daily dose (mg/day) should be administered in divided doses as specified in the dosing regimen. b: The supplemental dose refers to a dose administered once as an additional dose. 6. Patients with Hepatic Impairment No dose adjustment is necessary in patients with hepatic impairment. 8. Elderly patients (65 years of age or older) Dose reduction may be necessary in elderly patients with impaired renal function.
Children under 12 years of age: Use is not recommended because there are insufficient safety and efficacy data. Adolescent patients aged 12 ~17 years: Use is not recommended because there are insufficient safety and efficacy data.
This medication may increase the risk of suicidal thoughts or behaviors and mental health issues like depression. Therefore, patients and caregivers must immediately inform healthcare providers if such symptoms arise. Patients who are allergic to any ingredient in this drug should not take it, and individuals with lactose intolerance or specific genetic metabolic disorders should also avoid it. Diabetic patients may experience weight gain after taking this medication, possibly requiring dosage adjustments of blood sugar control medications. If severe allergic reactions like angioedema occur, immediately discontinue the medication and consult healthcare professionals. Elderly patients may experience increased dizziness or drowsiness, which heightens the risk of falls or accidents, thus caution is advised. This medication may cause visual disturbances or changes in vision; if such symptoms occur, consult a doctor. Abrupt discontinuation of this drug may lead to withdrawal symptoms like insomnia, headaches, and anxiety; it should be tapered off gradually as per the doctor’s recommendations. Combining it with other medications affecting the central nervous system may increase the risk of drug abuse or dependence; hence, patients should inform their doctors about their medical history and current medications. Patients with reduced kidney function should have their dosage adjusted, and those with severe heart conditions should take it with caution. There is a heightened risk of central nervous system depression when this drug is taken with opioid analgesics, so caution is advised. During early pregnancy, it may affect the fetus, therefore women of childbearing age should use effective contraception, and during pregnancy, taking the drug should carefully weigh maternal and fetal risks and benefits. Breastfeeding mothers need to consult their doctors about the potential transmission of this drug through breast milk to the baby, and may consider stopping breastfeeding or the medication. Activities requiring concentration such as driving or operating dangerous machinery should be avoided until symptoms are assessed, as dizziness or drowsiness may occur after taking this drug. Overdose may result in confusion, drowsiness, depression, seizures, etc., and such cases need immediate hospital treatment. This medication must be kept out of reach of children, and transferring it to other containers should be avoided due to the risk of decreased quality or accidents.
Suicidal thoughts, suicidal behavior, depression, abnormal changes in mood and behavior, angioedema, facial edema, perioral edema, upper airway edema, dizziness, drowsiness, loss of consciousness, confusion, mental disorders, blurred vision, visual changes, insomnia, headache, nausea, anxiety, diarrhea, influenza-like illness, restlessness, depression, pain, hyperhidrosis, misuse, abuse, dependence, congestive heart failure, severe respiratory depression, rhinitis, neutropenia, increased appetite, loss of appetite, hypoglycemia, confusion, disorientation, irritability, euphoria, decreased libido, depersonalization, paraphilia, agitation, mood swings, emotional lowering, emotional elevation, hallucinations, abnormal dreams, increased libido, panic attack, impulsivity, apathy, ataxia, abnormal coordination, balance disorders, amnesia, attention disorders, memory disorders, tremors, dysarthria, sensory abnormalities, sensory loss, sedation, somnolence, cognitive impairment, nystagmus, speech disorders, muscle cramps, diminished reflexes, movement disorders, psychomotor agitation, positional dizziness, hypersensitivity, burning sensation, activity tremor, syncope, confusion, hypokinesia, anosmia, ageusia, writing disability, blurred vision, diplopia, indirect vision loss, visual disturbances, visual field defects, photopsia, dry eye, eyelid swelling, visual impairment, eye pain, eye fatigue, increased lacrimation, eye irritation, mydriasis, changes in depth perception during vibration, strabismus, brightness of vision, dizziness, auditory hypersensitivity, first-degree heart block, tachycardia, bradycardia, sinus tachycardia, sinus arrhythmia, hypotension, hypertension, flushing, facial flushing, peripheral coldness, dyspnea, epistaxis, cough, nasal congestion, rhinitis, snoring, pharyngeal tension, nasal dryness, respiratory depression, vomiting, abdominal distension, constipation, dry mouth, abdominal bloating, hypersalivation, gastroesophageal reflux disease, oral sensory impairment, ascites, dysphagia, pancreatitis, sweating, papular rash, urticaria, cold sweating, muscle cramps, arthralgia, back pain, limb pain, cervical cramps, joint swelling, myalgia, muscle spasms, neck pain, muscle rigidity, rhabdomyolysis, urinary disorders, urinary incontinence, decreased urination, renal failure, erectile dysfunction, delayed ejaculation, sexual dysfunction, dysmenorrhea, amenorrhea, mastalgia, breast discharge, gynecomastia, peripheral edema, edema, gait abnormalities, falls, feeling of intoxication, sensory abnormalities, fatigue, chest tightness, generalized edema, pain, fever, chills, weakness, thirst, weight gain, increase in alanine aminotransferase, increase in serum creatine phosphokinase, increase in aspartate aminotransferase, increased blood sugar, decreased platelet count, decreased serum potassium, weight loss, increased serum creatinine, decreased white blood cell count, hypersensitivity, allergic reactions, headache, keratitis, pulmonary edema, nausea, diarrhea, tongue swelling, itching, Stevens-Johnson syndrome, toxic epidermal necrolysis, urinary retention, gynecomastia, lethargy, delirium, paralysis, affective disorder, drowsiness, confusion state, agitation, restlessness, seizures, worsening of convulsions, gastrointestinal disorders, tinnitus, sleep disorders, skin diseases, increased BUN, hematochezia
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid exposure to air or moisture, and it is important to keep it at a cool room temperature between 15 to 30 degrees Celsius.
A hard capsule with a white or slightly yellow powder inside, with a white upper and lower part.
30 capsules/bottle, 100 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Pregabalin 150mg
Hard capsule · Prescription medication
Light Pharmtech Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.